Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.

AIDS (London, England) - 2 Jan 2006

Sabin Caroline A, Smith Colette J, Youle Mike, Lampe Fiona C, Bell Di Robertson, Puradiredja Dewi, Lipman Marc C I, Bhagani Sanjay, Phillips Andrew N, Johnson Margaret A

Abstract excerpt

OBJECTIVES: To describe the characteristics of deaths that occur among HIV-positive individuals in the HAART era. DESIGN: Observational database. METHODS: Deaths were reviewed that occurred among HIV-positive individuals seen at the Royal Free Hospital, London between January 1998 and December 2003. RESULTS: Over the study period, there were 121 deaths; death rates declined from approximately 2.0/100 person-years...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cause of Death

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Viral

Share to HIV Infections

Share to HIV Seropositivity

Share to London

Source

Identifiers

PMID: 16327321
DOI: 10.1097/01.aids.0000196178.73174.24

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.PMID 16327321Read ↗

Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).Semantic proximity Read ↗

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.Semantic proximity Read ↗

Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.Semantic proximity Read ↗

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial.Semantic proximity Read ↗

Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.Semantic proximity Read ↗

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.Semantic proximity Read ↗

Mega-HAART: preliminary results and correlation with baseline resistance.Semantic proximity Read ↗

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.Semantic proximity Read ↗

Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.